Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing

The collaboration leverages Colossal’s marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines…

Colossal Labs will release the sounds of dire wolves howling 'later this year,' founder says |

Jun 4, 2025 View From the Top by Raj Verma CEO SingleStore There’s an issue in the world of databases that’s slowing the progress of…